SynBioBeta Deep Dive – Amyris and Labcyte: Increasing strain construction efficiency and reducing reaction volumes
News Digest #248 – Twist’s IPO, IndieBio’s demo day, Synlogic’s new data and Ginkgo’s de-extinct scent.
Genomatica Completes $90 Million Financing to Drive Technologies for More Sustainable Everyday Products
Amyris Enters into Extensive Collaboration Agreement with Leading Chinese Pharmaceutical Company, Yifan Pharmaceutical Co., Ltd.
Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines
